Ameriprise
IHE icon

Ameriprise’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Ameriprise’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.06M Buy
46,842
+21,289
+83% +$1.86M ﹤0.01% 2573
2025
Q4 		$2.17M Buy
25,553
+332
+1% +$26.5K ﹤0.01% 2951
2025
Q3 		$1.83M Buy
25,221
+1,563
+7% +$108K ﹤0.01% 3050
2025
Q2 		$1.55M Buy
23,658
+19,661
+492% +$1.28M ﹤0.01% 3081
2025
Q1 		$282K Sell
3,997
-1,233
-24% -$85.7K ﹤0.01% 3696
2024
Q4 		$344K Buy
5,230
+966
+23% +$66.5K ﹤0.01% 3669
2024
Q3 		$301K Sell
4,264
-126
-3% -$8.78K ﹤0.01% 3641
2024
Q2 		$291K Sell
4,390
-909
-17% -$59.6K ﹤0.01% 3592
2024
Q1 		$360K Sell
5,299
-680
-11% -$45K ﹤0.01% 3533
2023
Q4 		$369K Sell
5,979
-1,479
-20% -$86.9K ﹤0.01% 3557
2023
Q3 		$440K Buy
7,458
+2,532
+51% +$155K ﹤0.01% 3452
2023
Q2 		$294K Sell
4,926
-10,389
-68% -$618K ﹤0.01% 3611
2023
Q1 		$895K Buy
15,315
+1,545
+11% +$93.1K ﹤0.01% 3209
2022
Q4 		$783K Buy
13,770
+933
+7% +$56.1K ﹤0.01% 3233
2022
Q3 		$726K Sell
12,837
-21
-0.2% -$1.29K ﹤0.01% 3253
2022
Q2 		$824K Buy
12,858
+7,875
+158% +$500K ﹤0.01% 3198
2022
Q1 		$323K Sell
4,983
-294
-6% -$18.6K ﹤0.01% 3618
2021
Q4 		$351K Buy
5,277
+183
+4% +$11.6K ﹤0.01% 3625
2021
Q3 		$311K Buy
5,094
+99
+2% +$6.29K ﹤0.01% 3553
2021
Q2 		$309K Sell
4,995
-1,950
-28% -$119K ﹤0.01% 3631
2021
Q1 		$411K Sell
6,945
-4,185
-38% -$252K ﹤0.01% 3477
2020
Q4 		$664K Buy
11,130
+1,206
+12% +$68.7K ﹤0.01% 3243
2020
Q3 		$541K Sell
9,924
-1,401
-12% -$75.6K ﹤0.01% 3212
2020
Q2 		$581K Buy
11,325
+2,727
+32% +$137K ﹤0.01% 3147
2020
Q1 		$386K Sell
8,598
-447
-5% -$22.5K ﹤0.01% 3218
2019
Q4 		$483K Buy
9,045
+948
+12% +$46.7K ﹤0.01% 3344
2019
Q3 		$377K Sell
8,097
-798
-9% -$38.2K ﹤0.01% 3386
2019
Q2 		$448K Sell
8,895
-79,404
-90% -$3.93M ﹤0.01% 3373
2019
Q1 		$4.53M Buy
88,299
+6,048
+7% +$301K ﹤0.01% 2294
2018
Q4 		$3.86M Buy
82,251
+1,173
+1% +$60.1K ﹤0.01% 2298
2018
Q3 		$4.54M Sell
81,078
-41,013
-34% -$2.24M ﹤0.01% 2400
2018
Q2 		$6.16M Buy
122,091
+2,931
+2% +$145K ﹤0.01% 2096
2018
Q1 		$5.83M Buy
119,160
+13,269
+13% +$681K ﹤0.01% 2062
2017
Q4 		$5.45M Sell
105,891
-7,878
-7% -$405K ﹤0.01% 2064
2017
Q3 		$5.94M Buy
113,769
+13,827
+14% +$710K ﹤0.01% 1969
2017
Q2 		$5.1M Buy
99,942
+3,264
+3% +$165K ﹤0.01% 2063
2017
Q1 		$4.87M Buy
96,678
+16,947
+21% +$839K ﹤0.01% 2072
2016
Q4 		$3.76M Buy
79,731
+47,760
+149% +$2.27M ﹤0.01% 2275
2016
Q3 		$1.59M Buy
31,971
+2,949
+10% +$150K ﹤0.01% 2686
2016
Q2 		$1.4M Buy
29,022
+3,537
+14% +$168K ﹤0.01% 2716
2016
Q1 		$1.15M Buy
25,485
+12,204
+92% +$571K ﹤0.01% 2783
2015
Q4 		$716K Sell
13,281
-1,869
-12% -$98.3K ﹤0.01% 3100
2015
Q3 		$747K Buy
15,150
+5,310
+54% +$304K ﹤0.01% 3096
2015
Q2 		$573K Buy
9,840
+450
+5% +$26.3K ﹤0.01% 3374
2015
Q1 		$540K Buy
9,390
+216
+2% +$11.8K ﹤0.01% 3173
2014
Q4 		$463K Buy
9,174
+3,564
+64% +$174K ﹤0.01% 3152
2014
Q3 		$262K Sell
5,610
-915
-14% -$41.3K ﹤0.01% 3292
2014
Q2 		$294K Sell
6,525
-1,560
-19% -$67.1K ﹤0.01% 3168
2014
Q1 		$341K Sell
8,085
-147
-2% -$6.16K ﹤0.01% 3069
2013
Q4 		$324K Buy
8,232
+777
+10% +$29.1K ﹤0.01% 2988
2013
Q3 		$267K Buy
7,455
+2,388
+47% +$84.1K ﹤0.01% 3065
2013
Q2 		$168K Buy
+5,067
New +$168K ﹤0.01% 3163

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Ameriprise's IHE Position: Q1 2026 in Review

Ameriprise increased its iShares US Pharmaceuticals ETF (IHE) stake by 83% in Q1 2026, buying an estimated $1.86M and bringing the position to 46,842 shares worth $4.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2573.

Ameriprise first reported a position in IHE in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.16M in Q2 2018. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

  • Ameriprise held 46,842 shares of iShares US Pharmaceuticals ETF worth $4.06M as of Q1 2026.
  • Ameriprise bought 21,289 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $1.86M.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2573 holding.
  • Ameriprise first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and has held it in 52 quarters since.
  • Ameriprise's iShares US Pharmaceuticals ETF position peaked at $6.16M in Q2 2018.
  • 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.